In the last 12 months, insiders at Coeptis Therapeutics Holdings, Inc. ($COEP) filed 50 transactions with the SEC: 13 open-market purchases totaling $83,268 and 0 sales totaling $0. Net insider sentiment: net buying.
Coeptis Therapeutics Holdings, Inc. operates in the Finance services industry (Finance or office of crypto assets sector).
Most Active Insiders
- Mehalick David (CEO and President) — 9 transactions totaling $1,066,316
- Cogley Brian (Chief Financial Officer) — 4 transactions totaling $108,950
- Yerace Daniel Alexander (VP Operations) — 2 transactions totaling $104,100
- Salkind Gene (Director) — 7 transactions totaling $98,303
- Calise Chris (Director) — 6 transactions totaling $71,071
View all SEC Filings for Coeptis Therapeutics Holdings, Inc. (COEP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Cochran Christopher P. | Director | M | Common stock | 5700 | $10.56 | 8,950.0000 | 4,745,089 | 175.38% | 0.12% |
| Feb. 11, 2026 | Mehalick David | CEO and President | M | Common stock | 148875 | $7.05 | 330,192.0000 | 4,745,089 | 82.11% | 3.14% |
| Feb. 11, 2026 | Calise Chris | Director | A | Common stock | 3250 | $0.00 | 368,741.0000 | 4,745,089 | 0.89% | 0.07% |
| Feb. 11, 2026 | Calise Chris | Director | M | Common stock | 5700 | $10.56 | 368,741.0000 | 4,745,089 | 1.57% | 0.12% |
| Feb. 11, 2026 | Deschamps Philippe | Director | A | Common Stock | 3250 | $0.00 | 8,950.0000 | 4,745,089 | 57.02% | 0.07% |
| Feb. 11, 2026 | Deschamps Philippe | Director | M | Common stock | 5700 | $10.56 | 8,950.0000 | 4,745,089 | 175.38% | 0.12% |
| Feb. 11, 2026 | Cogley Brian | Chief Financial Officer | A | Common Stock | 12500 | $0.00 | 22,500.0000 | 4,745,089 | 125.00% | 0.26% |
| Feb. 11, 2026 | Cogley Brian | Chief Financial Officer | M | Common stock | 10000 | $10.56 | 22,500.0000 | 4,745,089 | 80.00% | 0.21% |
| Feb. 11, 2026 | Mehalick David | CEO and President | A | Common Stock | 51250 | $0.00 | 330,192.0000 | 4,745,089 | 18.37% | 1.08% |
| Feb. 11, 2026 | Sheehy Christine Elise | VP Compliance and Secy | A | Common Stock | 12500 | $0.00 | 64,031.0000 | 4,745,089 | 24.26% | 0.26% |
| Feb. 11, 2026 | Sheehy Christine Elise | VP Compliance and Secy | M | Common stock | 1000 | $10.56 | 64,031.0000 | 4,745,089 | 1.59% | 0.02% |
| Feb. 11, 2026 | DeSilva Tara | Director | A | Common Stock | 3250 | $0.00 | 8,950.0000 | 4,745,089 | 57.02% | 0.07% |
| Feb. 11, 2026 | DeSilva Tara | Director | M | Common stock | 5700 | $10.56 | 8,950.0000 | 4,745,089 | 175.38% | 0.12% |
| Feb. 11, 2026 | Salkind Gene | Director | A | Common Stock | 3250 | $0.00 | 13,161.0000 | 4,745,089 | 32.79% | 0.07% |
| Feb. 11, 2026 | Salkind Gene | Director | M | Common stock | 5700 | $10.56 | 13,161.0000 | 4,745,089 | 76.40% | 0.12% |
| Feb. 11, 2026 | Yerace Daniel Alexander | VP Operations | A | Common Stock | 20000 | $0.00 | 70,531.0000 | 4,745,089 | 39.58% | 0.42% |
| Feb. 11, 2026 | Yerace Daniel Alexander | VP Operations | M | Common stock | 10000 | $10.41 | 70,531.0000 | 4,745,089 | 16.52% | 0.21% |
| Feb. 11, 2026 | Cochran Christopher P. | Director | A | Common Stock | 3250 | $0.00 | 8,950.0000 | 4,745,089 | 57.02% | 0.07% |
| March 4, 2025 | Deschamps Philippe | Director | A | Non-qualified Stock Options (right to buy) | 5700 | $0.00 | 8,950.0000 | 1,924,639 | 175.38% | 0.30% |
| March 4, 2025 | DeSilva Tara | Director | A | Non-qualified Stock Options (right to buy) | 5700 | $0.00 | 8,950.0000 | 1,924,639 | 175.38% | 0.30% |
| March 4, 2025 | Cogley Brian | Chief Financial Officer | A | Non-Qualified Stock Options (right to buy) | 10000 | $0.00 | 22,500.0000 | 1,924,639 | 80.00% | 0.52% |
| March 4, 2025 | Yerace Daniel Alexander | VP of Operations | A | Non-Qualified Stock Options (right to buy) | 5000 | $0.00 | 25,000.0000 | 1,924,639 | 25.00% | 0.26% |
| March 4, 2025 | Sheehy Christine Elise | VP Compliance and Secy | A | Non-Qualified Stock Options (right to buy) | 1000 | $0.00 | 13,500.0000 | 1,924,639 | 8.00% | 0.05% |
| March 4, 2025 | Salkind Gene | Director | A | Non-qualified Stock Options (right to buy) | 5700 | $0.00 | 8,950.0000 | 1,924,639 | 175.38% | 0.30% |
| March 4, 2025 | Mehalick David | CEO and President | A | Non-Qualified Stock Options (right to buy) | 28875 | $0.00 | 200,125.0000 | 1,924,639 | 16.86% | 1.50% |
| March 4, 2025 | Cochran Christopher P. | Director | A | Non-qualified Stock Options (right to buy) | 5700 | $0.00 | 8,950.0000 | 1,924,639 | 175.38% | 0.30% |
| March 4, 2025 | Calise Chris | Director | A | Non-qualified Stock Options (right to buy) | 5700 | $0.00 | 8,950.0000 | 1,924,639 | 175.38% | 0.30% |
| Jan. 10, 2024 | Cogley Brian | Chief Financial Officer | P | Common Stock | 5000 | $0.67 | 30,000.0000 | 1,284,499 | 20.00% | 0.39% |
| Jan. 12, 2024 | DeSilva Tara | Director | P | Common Stock | 1800 | $0.58 | 32,266.0000 | 1,284,499 | 5.91% | 0.14% |
| Jan. 12, 2024 | DeSilva Tara | Director | P | Common Stock | 466 | $0.56 | 30,466.0000 | 1,284,499 | 1.55% | 0.04% |
| Jan. 5, 2024 | Mehalick David | CEO and President | P | Common Stock | 5050 | $0.69 | 2,762,611.0000 | 1,284,499 | 0.18% | 0.39% |
| Jan. 8, 2024 | Mehalick David | CEO and President | P | Common Stock | 6000 | $0.67 | 2,768,611.0000 | 1,284,499 | 0.22% | 0.47% |
| Jan. 8, 2024 | Mehalick David | CEO and President | P | Common Stock | 14004 | $0.66 | 2,782,615.0000 | 1,284,499 | 0.51% | 1.09% |
| Jan. 5, 2024 | Cochran Christopher P. | Director | P | Common Stock | 7000 | $0.77 | 37,000.0000 | 1,284,499 | 23.33% | 0.54% |
| Jan. 5, 2024 | Yerace Daniel Alexander | VP of Operations | P | Common Stock | 10850 | $0.69 | 1,071,455.0000 | 1,284,499 | 1.02% | 0.84% |
| Jan. 5, 2024 | Salkind Gene | Director | P | Common Stock | 11600 | $0.69 | 316,740.0000 | 1,284,499 | 3.80% | 0.90% |
| Dec. 7, 2023 | Mehalick David | CEO and President | G | Common Stock | 700000 | $0.00 | 2,757,561.0000 | 0 | 20.25% | 0.00% |
| Aug. 23, 2023 | Calise Chris | Director | P | Common Stock | 2582 | $0.94 | 1,464,897.0000 | 0 | 0.18% | 0.00% |
| Aug. 23, 2023 | Calise Chris | Director | P | Common Stock | 9000 | $0.94 | 1,462,315.0000 | 0 | 0.62% | 0.00% |
| Aug. 25, 2023 | Salkind Gene | Director | P | Common Stock | 28638 | $0.91 | 278,684.0000 | 0 | 11.45% | 0.00% |
| Aug. 29, 2023 | Salkind Gene | Director | P | Common Stock | 4006 | $1.01 | 254,092.0000 | 0 | 1.60% | 0.00% |
| Jan. 27, 2023 | Sheehy Christine Elise | CFO and Secretary | A | Incentive Stock Options (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Salkind Gene | Director | A | Non-qualified Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Mehalick David | CEO and President | A | Non-qualified Stock Options (right to buy) | 375000 | $0.00 | 375,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Calise Chris | Director | A | Non-qualified Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Cochran Christopher P. | Director | A | Non-qualified Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Deschamps Philippe | Director | A | Non-qualified Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | DeSilva Tara | Director | A | Non-qualified Stock Options (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Mehalick David | CEO and President | A | Incentive Stock Options (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 27, 2023 | Yerace Daniel Alexander | VP of Operations | A | Incentive Stock Options (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |